Skip to main content
OpenTrials
Completed

NCT Number: NCT00862667

A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers.

The purpose of this study is to investigate the time course of PF-00241939 concentration in the blood following dosing by oral inhalation from dry powder inhalers.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

21 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Pfizer Investigational Site

Singapore, 188770

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy male and/or female subjects between the ages of 21 and 55 years.
  • Body Mass Index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight >50 kg (110 lbs).

Exclusion criteria

  • Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease (including drug allergies, but excluding untreated, asymptomatic, seasonal allergies at time of dosing).
  • A positive urine drug screen.
  • History of regular alcohol consumption exceeding 14 drinks/week for females or 21 drinks/week for males.
  • Pregnant or nursing females.

Treatment and study plan

Treatment A

Drug

PF-00241939 300ug using Inhaler A

Treatment B

Drug

PF-00241939 300ug using Inhaler B

Treatment C

Drug

PF-00241939 300ug using Inhaler C

Primary outcomes

  1. Plasma pharmacokinetic parameters: AUClast & Cmax.

    Time frame: 48 hours

Secondary outcomes

  1. Plasma pharmacokinetic parameters: AUC0-12, AUC0-24, AUCinf, Tmax and t½.

    Time frame: 48 hours

Sponsors and collaborators

Lead sponsor

Pfizer

Industry

Registry information

Official study title

An Open Study To Estimate The Plasma Pharmacokinetics Of PF-00241939 Administered Via Oral Inhalation Using Dry Powder Inhalers.

Acronym: B0871002

Important dates

Study start
2009
Primary completion
2009
Study completion
2009
First posted
Mar 17, 2009
Registry last updated
Jun 24, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.